The Netherlands Consortium for Healthy Ageing (NCHA) is an alliance between the Leiden University Medical Centre, the Erasmus Medical Centre, Unilever, Philips Healthcare and Galápagos. NCHA is supported by the Netherlands Genomics Initiative.
Our Objective
Our life expectancy is steadily rising. Unfortunately, old age is accompanied by a growing vulnerability to disease. Experimental evidence shows that the undesirable effects of ageing are far more amenable for intervention than is generally assumed. NCHA seeks a thorough understanding of the (healthy) ageing process and of age-related diseases. It studies interventions that may be applied to protect and preserve health: new ways for prevention, diagnosis, prognosis, treatment and self-management regarding age-related disease.
Our mission and vision
NCHA promotes healthy ageing:
- By correcting the research deficit regarding the elderly;
- By adapting health care facilities to the needs of older patients;
- By finding novel interventions for disabilities, using innovative strategies derived from technology and the life sciences;
- Together with developing effective public health interventions for conserving an independent lifestyle;
- Ultimately leading to a ‘silver economy’.
Our strategy
NCHA research focuses on the principle drivers that allow people to successfully reach longevity in good health. We put older people central and follow an integrated approach instead of the traditional strategies to cope with various diseases separately.
Who is who l more about our experts
Management team:
André Uitterlinden (scientific director)
Eline Slagboom (scientific director)
Annette de Deugd-van Kalkeren (managing director)
Valorisation team:
Frans van der Ouderaa, director
Nicky Vogels
Rob Posthumus
Principal investigators:
See Research
